Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Denosumab may cause alopecia areata.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

MK-386 lowers DHT in blood and skin but not in semen.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Biomimetic peptides were found to promote hair growth and prolong the growth phase in human hair follicles.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Sesamin may help treat hair loss by affecting specific cell pathways.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

The man's symptoms improved and the tumor shrank after treatment with cabergoline.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.